Search
for

    Research

    5 / 1000+ results

    Community Join

    5 / 104 results

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

       118 upvotes 2 years ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community I hope ET-02 or PP405 will be released in the next 4-5 years

       18 upvotes 1 year ago
      PP405 is a potential hair loss treatment that may work by blocking signals that cause hair cells to stop growing, requiring daily application for effectiveness. It could serve as an alternative to minoxidil and finasteride, but it is not yet available on the market and may take several years to be released.

      community Hair transplants and PP405 - Irregular density concern

       18 upvotes 6 months ago
      The conversation discusses concerns about getting a hair transplant with the potential release of a new treatment, PP405, which may regrow dormant hair follicles. The user is currently using Minoxidil, Derma, and Keto but is waiting to start finasteride or dutasteride.
      PP405 Identity Research

      community PP405 Identity Research

      in Research  292 upvotes 1 year ago
      PP405 is a potential hair loss treatment that inhibits mitochondrial pyruvate carriers, increasing lactate dehydrogenase activity and stimulating hair follicle stem cells. In a phase 1 trial, 31% of participants showed over 20% hair density increase with PP405 treatment.